ABSTRACT. Our report presents data on maturation of the vitamin K-dependent carboxylation system in fetal and neonatal rat livers. This system which converts precursors of clotting factors 11, VII, IX, X, protein S, and protein C to y-carboxylated proteins exhibited low y-carboxylation activity before birth. However, around the time of birth there was a sudden increase in all enzyme activities associated with the vitamin K-dependent carboxylation system. In 2-d neonatal rats these activities dropped to levels that were measured in fetal livers whereupon the activities had risen to adult levels in 7-d neonatal rats. However, the activities of the two pathways that provide the carboxylase with reduced vitamin KH2 cofactor were never as high as that measured in maternal livers. It appeared that the pathway which is insensitive to coumarin anticoagulant drugs matures later than the coumarin drug-sensitive pathway. This conclusion is supported by the finding of a late appearance in development of the vitamin K-reducing enzyme DT-diaphorase. Warfarin, when administered to the mother, affected the fetal livers at all stages of development studied (d 16-21). This was clearly demonstrated by vitamin K-dependent 14C-labeling of a 70-kD liver protein that has been shown previously to be a marker for the effect of this drug on the liver. The data demonstrate a similar mechanism of action of warfarin in fetal and neonatal rat livers and an ongoing maturation process of the vitamin Kdependent carboxylation system in these rats. (Pediatr Res 26: 370-376,1989) Abbreviations Vitamin KIH2, the fully reduced hydroquinone form of vitamin K1 Carboxylase activity, the activity of the enzyme that carries out y-carboxylation DTT. dithiothreitol It is well documented that premature infants and infants at term are born with reduced levels of many of the essential protein factors of the hemostatic system (1, 2). Among these are the vitamin K-dependent clotting factors (2, 3). At term, blood concentrations of these factors are about 30-60% of their con-
centrations in adult blood (2, 4) . The low concentrations are found in premature infants where bleeding problems are more frequent and often more severe (5) . Plasma concentrations of the vitamin K-dependent clotting factors have been shown to be dependent on gestational age (6) which has raised the question of whether the low concentrations found in the newborn would result from an immature system that produces these proteins.
Kisker et al. (7) have shown recently that changes in the prothrombin antigen and activity levels in blood obtained from fetal lambs at various gestational ages are paralleled by changes in the levels of prothrombin messenger RNA present in liver. Similar results were reported by Hassan et al. (8) when they extracted RNA from fetal liver obtained at abortion in the first trimester of human pregnancy. Indeed, vitamin K-dependent clotting factor production by the liver is dependent upon available mRNA and protein synthesis. However synthesis of these proteins are, in addition, dependent on a vitamin K-dependent carboxylation system that modifies the proteins postribosomally (9) to convert them to the mature y-carboxylated Ca++ binding proteins (10) . This system harbors several enzymes which are necessary for vitamin K-dependent clotting factor production by the liver ( 1 1). The clotting factors are y-carboxylated by the vitamin Kdependent carboxylase that uses reduced vitamin K1 hydroquinone as cofactor for the reaction (1 1). In the liver, where vitamin K1 is received as the quinone, the quinone is reduced to the active cofactor by enzymes belonging to two independent reduction pathways. These are: I ) pathway I, a pathway catalyzed by vitamin K epoxide reductase, an enzyme that is highly sensitive to inhibition by coumarin anticoagulant drugs; 2) pathway 11, a pathway catalyzed by pyridine nucleotide-dependent enzymes that are less sensitive to inhibition by these drugs (1 1). Warfarin, one of the coumarin drugs, has been shown to inhibit pathway I irreversibly (12) . Pathway I1 mediates the antidotal effect of vitamin K1 in overcoming poisoning by coumarin anticoagulant drugs (13) . This system for vitamin K function and vitamin K metabolism has been shown to be similar in rats and humans (1 1) .
In our study we have investigated in fetal and neonatal rat livers the normal events leading to maturation of the vitamin Kdependent carboxylation system. Our data demonstrate an ongoing maturation process of the system in fetal and neonatal rats. Significant changes in the system were found around birth.
MATERIALS AND METHODS
Animals. Time-pregnant Sprague-Dawley rats were purchased from Zivic-Miller Laboratories, Inc. (Zelienople, PA). Rats were divided into groups according to gestational age and five rats VITAMIN K AND DEVELOPMENT 37 1 were used in each group. All pregnant rats and neonatal rats treated with warfarin were given 30 mg/kg of the drug intraperitoneally in saline 24 h before death. Control animals received the same quantity of saline. Warfarin-treated and control animals were killed on d 16, 17, 18, 19 , and 20 before birth, at birth (d 21) and on d 2 and 7 after birth. Before death by decapitation all rats were anesthetized with pentobarbital.
Preparation of Liver Microsomes. Livers from fetal rats, neonatal rats, and mothers in the various groups were each pooled separately and homogenized in 250 mM sucrose, 25 mM imidazole, pH 7.2, containing 5 mM benzamidine (buffer A) as described (1 1). The homogenate was centrifuged twice at 10 000 x g for 10 min and then at 100 000 x g for 60 min to obtain a microsomal pellet. The pellets from the 100 000 x g spin were resuspended in buffer A and pelleted a second time by centrifugation at 100 000 x g for 60 min. The final microsomal pellets were stored in liquid N2.
Measurements of Enzyme Activities. Vitamin K-dependent carboxylase. Vitamin K-dependent carboxylase activity was measured as I4CO2 incorporation into the synthetic peptide substrate Phe-Leu-Glu-Glu-Leu (peptide carboxylation) and also as 14C02 incorporation into endogenous microsomal protein substrates (protein carboxylation) (14) . All activity measurements were carried out in buffer B (25 mM imidazole, 5 mM benzamidine, 0.5% 3-[(3-cholamidopropy1)-dimethylammonio]-1-propanesulfonate, pH 7.2) in the presence of 1 mM MnClz and 5 mM DTT as described (1 1). Incubations with chemically reduced vitamin KIH2 contained 100 pg/mL of the reduced vitamin. Carboxylase activity supported by pathway I and I1 was measured as follows. Pathway I supported: incubations contained 100 pg/mL of vitamin KI quinone. Pathway I1 supported: incubations contained 100 pg/mL of vitamin K I quinone, 2 mM NADH and 50 pM warfarin for inhibition of pathway I.
Vitamin K epoxide reductase. Vitamin K epoxide reductase activity was measured in microsomes resuspended in buffer A. Incubations contained 10 pM of vitamin K I 2,3 epoxide and 5 mM DTT. Activity was measured as % conversion of the epoxide to vitamin K I quinone using an HPLC system for separation of the two components. The assay system is described in detail elsewhere (9) .
DT diaphorase. DT diaphorase (E.C. 1.6.99.2) activity was measured in lung and liver cytosol as reduction by NADH of the dye 2,6-dichlorophenol indophenol. The assay system is described in detail elsewhere (15) .
Prothrombin Precursor. The microsomal concentration of the prothrombin precursor was measured by immunodot blotting as described by Reiderer et al. (16) . For this assay the microsomal pellet was dissolved in 250 mM sucrose, 25 mM imidazole, 0.5 M KCl, 1.5% Triton X-100, pH 7.2. Aliquots of 1-2 pL were spotted on nitrocellulose membranes that were reacted subsequently with rat prothrombin antibodies and 1251-protein A as described (1 7). Rat plasma containing 1.5 % Triton X-100 and 0.5 M KC1 was used as standard for estimation of the prothrombin precursor concentration. A plasma concentration of 0.1 mg/ mL was assumed for prothrombin. Rabbit antiserum against rat prothrombin was obtained as described (17) .
Plasma Prothrombin Time. Blood was drawn from the vena cava into 2.85% sodium citrate (blood/citrate ratio; 9: 1 vol/vol). Blood samples from all five rats within each group were pooled. Prothrombin time was determined with rabbit brain thromboplastin as described in the instruction manual from the supplier (Sigma Chemical Co., St. Louis, MO).
I4C-Labeling of Microsomal Carboxylase Substrates. Endogenous protein substrates for the carboxylase in microsomes from fetal and adult rat livers were I4C-labeled according to a protocol described in (17) . Briefly, microsomes suspended in buffer B were incubated for 30 min at 25°C in the presence of 1 mM MnC12, 5 mM DTT, 40 pCi/mL of HI4CO3-and 100 pg/mL of reduced vitamin KIH2. The incubation mixture was gel filtrated on Sephadex G-25 in 10 mM NH4HC03, 5 mM benzamidine, and the void volume fraction lyophilized and subjected to SDS-PAGE.
SDS-PAGE and Fluorography. SDS-PAGE was carried out according to Laemmli (1 8) in 10% reducing gels. Before electrophoresis, all samples were boiled for 2 min in the presence of 5% mercaptoethanol and 2% SDS. I4C-methylated standard proteins (Amersham Corp., Arlington Heights, IL) were used for M, determinations. Gels selected for fluorography were fixed over night in 10% trichloroacetic acid, 10% acetic acid, 25% methanol, and treated with EN3HANCE (New England Nuclear, Boston, MA) for 1 h. The dried gel was exposed to Kodak X-Omat XAR-5 film (Eastman Kodak, Rochester, NY) at -70°C for 4 weeks.
Materials. Vitamin K I used for preparation of chemically reduced vitamin KIH2 was from Sigma. The vitamin was reduced with dithionite as described by Sadowski et al. (19) . Vitamin KI quinone used in the assay system was the commercial preparation Aquamephyton obtained from Merck Sharp and Dohme, West Point, PA. NaHI4CO3 (60 mCi/mmol) and '251-Protein A (>30 mCi/mg) were from Amersham.
The pentapeptide Phe-Leu-Glu-Glu-Leu was from Vega Fox Biochemicals, Tucson, AZ. Protein was measured using the BioRad (Bio-Rad Laboratories, Richmond, CA) protein assay. Phospholipids were measured as described by Bartlett (20) . Quantitative estimation of visible I4C-labeled protein bands on photographic films was performed with a Zenith soft Laser scanner.
RESULTS
Plasma from warfarin-treated pregnant rats had prothrombin times between 50 and 60 s which were significantly prolonged compared to prothrombin times in pooled plasma from salinetreated pregnant rats (1 3-14 s). Rats, 16 to 2 1 d pregnant, had shorter prothrombin times than nonpregnant adult rats but prothrombin time normalized shortly after delivery.
Before investigating vitamin K function and metabolism in fetal liver microsomes, it was necessary to identify these subcellular particles isolated from livers in various stages of development. We chose to investigate the proteins in fetal microsomes as they appear in SDS-PAGE gels after staining with Coomassie brilliant blue. Thus, microsomal proteins from fetal livers were subjected to SDS-PAGE in 10% reducing gels. As shown in Figure 1 , the protein patterns of microsomes from d 16, 17, 18, 19 , and 20 fetal rats was quite similar, suggesting that the subcellular particles we had isolated indeed were derived from the same cellular organelles. The protein pattern of adult liver microsomes is also shown (Fig. 2, lane A) . As shown, there was a strong degree of similarity between the adult pattern and the fetal pattern. However, some change in the protein pattern occurred at birth (Fig. 2, lane 21) and this change was most apparent in the M, range 45-50 kD where cytochrome P-450 normally migrates in this gel system (21) .
These microsomes and also microsomes from 2-and 7-d neonatal rats were used to investigate their ability to carry out vitamin K-dependent y-carboxylation of the synthetic pentapeptide Phe-Leu-Glu-Glu-Leu (Fig. 2) . To compare the data obtained from livers in various stages of development it was necessary to relate all measurements to a stable parameter. In all microsomal preparations, phospholipid and protein were determined. We found, however, that the phospholipid to protein ratio increased toward birth. Thus, between the microsomal protein and phospholipid concentrations, protein was chosen as the most stable parameter. Therefore all data are expressed per mg of microsomal protein. In microsomes from fetal rats carboxylase activity increased toward birth (Fig. 2) . Changes in activity were most pronounced at birth where the activity in control fetal rats and fetal rats from mothers treated with warfarin had increased 1.4-and 1.6-fold, respectively, over the activity measured in d-20 fetal rats (Fig. 2, A and B) . In d-16 fetal rats, pathway 11-supported carboxylase activity could not be measured by our test system. However, significant activity was measured in d-17 fetal rats and in liver microsomes from more developed rats (Fig. 2) . However, significant pathway I-supported carboxylase activity was measured in d-16 fetal rats, which suggests an earlier emergence during development of the pathway I enzyme vitamin K epoxide reductase than the pyridine nucleotide-dependent enzymes catalyzing pathway 11. However, these activities were never as high as the activities measured in liver microsomes from the mothers (see Fig. 5 ).
During development of the fetus from d 16 to 2 1 (birth) some variation was found in the ability of pathway I and I1 to provide the carboxylase with reduced vitamin KIH2 cofactor (Fig. 2) . However, when measured relative to the activity of the vitamin K-dependent carboxylase our data showed no specific increase either in pathway I-or pathway 11-supported carboxylase activity toward birth. This suggests that the pathway I and I1 enzymes, during development of the rat fetus, do not emerge at a faster rate than the carboxylase enzyme. When compared to control rats, pathway I-supported carboxylase activity was inhibited 85% in microsomes from d-16 fetal livers obtained from mothers that had been injected with warfarin. Inhibition of this activity was also measured in microsomes from more developed warfarin-treated rats (see Fig. 2, inset) .
However, pathway 11-supported carboxylase activity was not affected by warfarin administration to the mother (compare Fig.  2, A and B) .
Carboxylase activity measured in microsomes from 2-d neonatal rats was reduced 50% from this activity measured in fetal liver microsomes at birth. This "dip" in activity was observed in control neonatal rats (Fig. 2, A ) as well as in neonatal rats treated with 30 mg/kg of warfarin (Fig. 2, B) . In 7-d neonatal rats the activity had risen to a level that was 2.5-fold higher than the activity measured in microsomes from the mothers (Fig. 2) . . DT diaphorase activity in liver and lung cytosol from fetal and neonatal rats. DT diaphorase activity was measured in lung (x) and liver (A) cytosol obtained from pooled fetal and neonatal rats. Enzyme activity was measured as reduction of the dye 2,6-dichlorophenol indophenol. The activity measured in liver and lung cytosol from normal adult rats is shown (A, adult).
In 2-and 7-d neonatal rats pathway I1 was clearly more active than at birth (Fig. 2A) . This apparent delay of the pathway I1 enzymes in development was supported by the finding of a late appearance in liver of one of the enzymes (DT-diaphorase) catalyzing this pathway (1 1).
As shown in Figure 3 , DT-diaphorase (EC. 1.6.99.2) activity is low in fetal livers. The activity increased in neonatal livers and had reached adult levels in 7-d neonates. Interestingly, this activity in fetal lung had reached adult levels already on d 17 of gestation (Fig. 3) . Thus, during development of the rat, the timing of emergence of this enzyme in lung and liver is quite different. However, the warfarin-sensitive pathway I enzyme, the vitamin K epoxide reductase, revealed significant activity in liver microsomes from d-16 fetal rats. Figure 4 shows this activity when measured in liver microsomes from fetal and neonatal livers (Fig.  4A ) and in livers from the mothers (Fig. 4B) , respectively. Also shown in Figure 4 is the significantly lower vitamin K epoxide reductase activity measured in liver microsomes from warfarintreated rats.
There was very little variation in the activities of the vitamin K-dependent carboxylation system in maternal livers before and after birth (Fig. 5) . As shown by inhibition of pathway I-supported carboxylase activity, warfarin had also affected the vitamin K-dependent carboxylation system in maternal livers (compare A and B in Fig. 5) .
Carboxylation of endogenous microsomal protein (protein carboxylation) was also measured in fetal and neonatal liver microsomes (Fig. 6 ). This activity that reflects carboxylation of the natural substrates for the vitamin K-dependent carboxylase, was enhanced about 1-fold in fetal liver microsomes from warfarin-treated mothers that again indicates an effect of warfarin on the fetus (10) .
The prothrombin precursor concentration in fetal liver microsomes increased toward birth and there was a marked increase in the concentration at birth (Fig. 7A) . Fetal and neonatal liver microsomes from warfarin-treated mothers had higher pro- thrombin precursor concentrations than microsomes prepared from saline-treated mothers (Fig. 7A) . Liver microsomes from pregnant and postpartum adult rats treated with warfarin revealed a 2.5-to 3-fold increase in the prothrombin precursor concentration over control rats treated with saline (Fig. 7B) . In these adult rats we measured a transient increase in the prothrombin precursor concentration around the time of birth but this increase was small compared to the increase measured in fetal liver microsomes at birth (compare Fig. 7, A and B) .
Recently we presented evidence that vitamin K-dependent 14C-labeling of a 70-kD microsomal protein in vitro is a marker for the effect of warfarin on the liver in vivo. The protein was identified as the factor X carboxylase substrate (17) . We used this test to evaluate the response of the fetal liver to this drug when administered to the mother. As a control, we used the test on liver microsomes isolated from pregnant rats. Indeed, liver microsomes isolated from pregnant rats treated with warfarin revealed, in addition to the 78-kD prothrombin precursor (17) and some other faintly I4C-labeled proteins, the heavily I4C-labeled 70-kD protein (Fig. 8, lane W) . In fetal liver microsomes from both warfarin- (Fig. 9 , panel W) and saline- (Fig. 9 , panel S) treated mothers, I4C-labeling of the 78-kD prothrombin precursor was seen from d 16 of gestation. However, I4C-labeling of the 70-kD protein was clearly visible only in microsomes prepared from fetal livers from warfarin-treated mothers (Fig. 9, panel W). This experiment strongly suggest that warfarin affects the fetal liver by a mechanism that is similar to its mechanism of action in the mother. 
DISCUSSION
Our report presents evidence for a maturation process of the vitamin K-dependent carboxylation system in the developing rat. The data demonstrate that coumarin anticoagulant drugs, when administered to the mother, affect the fetal liver by a mechanism that is similar to its mechanism of action in the adult liver. Clearly, warfarin reached the liver in d-16 fetuses and inhibited vitamin K epoxide reductase, the coumarin-sensitive enzyme of the vitamin K cycle (10) . Warfarin also induced the appearance of the 70-kD vitamin K-dependent protein that has been shown previously (17) to be a marker for the effect of this drug on the liver.
In d-16 fetal livers pathway 11-supported carboxylase activity could not be detected by our test system. Pathway 11, which is responsible for the antidotal effect of vitamin K (1 I), started to emerge in d-17 fetal livers. These data suggest that the rat fetus, until d 16 of gestation, is more vulnerable to coumarin intoxication than more developed rats. Reversal of the anticoagulant effect of coumarin drugs by pathway I1 would depend, of course, on whether or not enough vitamin K can reach the fetal liver to trigger-reduced vitamin KIH2 cofactor production by pathway 11. Inasmuch as the extent of placental transport of vitamin K, is still controversial (22, 23) this question remains unanswered.
Pathway I1 was clearly more active after birth in providing the carboxylase with reduced vitamin KlH2 cofactor. The idea of a more active pathway I1 after birth was supported by the finding of a late emergence of the pathway I1 enzyme, DT diaphorase, (1 1) in the developing liver. Shortly after birth, this activity increased dramaticallv. Because DT diavhorase is a vitamin Kreducing enzyme beldnging to reduction pathway I1 of the vitamin K-dependent carboxylation system (1 l), these data support our hypothesis that vitamin K would be more active as an antidote to overcome coumarin anticoagulant poisoning in neonates than in the fetus.
In 2-d neonatal rats, peptide carboxylase activity dropped to 50% of the activity measured at birth. This "dip" in activity found in 2-d neonatal rats coincided with a similar dip for protein carboxylase activity and a lower prothrombin precursor concentration in livers from these rats. Later experiments with pooled livers from other rat litters have shown that the "dip" can vary, but a dramatic increase in carboxylase activity around d 7 is always found. From studies with rat liver microsomes it has been shown that changes in peptide and protein carboxylation as well as the prothrombin precursor concentration follow the same pattern (24) . Thus, all the parameters measured do indeed suggest that a less efficient carboxylation system exists shortly after birth. The data are interesting in that human neonates often have a prolonged prothrombin time 2-3 days after birth (25, 26) . This physiologic dip has been considered to be a combination of vitamin K deficiency and hepatic immaturity (25) . Inasmuch as PIVKA factors (Proteins Induced in Vitamin K Absence) (27) rarely are found in neonatal blood, a vitamin K deficiency seems unlikely to be responsible for this phenomenon. Our data from the rat support the hypothesis of an immature vitamin Kdependent carboxylation system, which for unknown reasons, is down-regulated transitionally shortly after birth.
In the fetus, peptide and protein carboxylase activities and also the liver prothrombin precursor concentration peaked around birth. Although there was no significant change in carboxylase activity in the mothers, the prothrombin precursor concentration revealed a transient increase at that time. Inasmuch as the appearance of many enzymes in the developing liver has been shown (28) to be closely related to changes in the hormonal environment, these data are interesting in light of the profound hormonal changes that occur around birth (28) . Our data may indeed reflect hormonal control of maturation of the vitamin Kdependent carboxylation system. Such control can be exerted at the level of gene expression as well as at other sites along the biosynthetic route for these proteins. Whether or not maturation of the vitamin K-dependent carboxylation system is regulated by gene expression cannot be decided before the enzymes that constitute this system have been purified and cDNA probes are made available.
In developing tissues and organs specific enzymes are known to be expressed on time schedules, and these enzymes enable the growing organism to cope with the demands of fetal life and life after separation from the maternal environment. In premature neonates, normal development is interrupted. Such interruption may result in a hemostatic system where imbalances can occur easier, and this may be responsible for the more frequent bleeding complications experienced with premature neonates.
